Eli Lilly and Co

LLY: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
j#DLOCK|kqLOCK|^kV!>vW

Eli Lilly Earnings: Raising Our Fair Value Estimate on Strong Q2 and Higher Margin Expectations

Lilly reported 48% second-quarter revenue growth and 33% non-GAAP EPS growth, which included acquisition charges. Management raised the midpoints of its 2026 guidance to $86 billion in revenue and $36 per share in non-GAAP EPS. Shares rose 5% on Aug. 5.

Sponsor Center